Drug: gemcitabine Quarter: 2016Q3
Total Records: 1,060 Number of Pages: 53
| DRUGNAME | PT | EventCount |
|---|---|---|
| GEMCITABINE | Multiple organ dysfunction syndrome | 3 |
| GEMCITABINE | Muscular weakness | 3 |
| GEMCITABINE | Neoplasm progression | 3 |
| GEMCITABINE | Non-cardiac chest pain | 3 |
| GEMCITABINE | Palmar-plantar erythrodysaesthesia syndrome | 3 |
| GEMCITABINE | Pathogen resistance | 3 |
| GEMCITABINE | Pericardial effusion | 3 |
| GEMCITABINE | Peritonitis | 3 |
| GEMCITABINE | Pneumonitis | 3 |
| GEMCITABINE | Portal vein thrombosis | 3 |
| GEMCITABINE | Posterior reversible encephalopathy syndrome | 3 |
| GEMCITABINE | Pulmonary congestion | 3 |
| GEMCITABINE | Pulmonary tuberculosis | 3 |
| GEMCITABINE | Skin toxicity | 3 |
| GEMCITABINE | Small intestinal obstruction | 3 |
| GEMCITABINE | Therapeutic response decreased | 3 |
| GEMCITABINE | Thrombosis | 3 |
| GEMCITABINE | Toxic neuropathy | 3 |
| GEMCITABINE | Urinary tract obstruction | 3 |
| GEMCITABINE | Vocal cord paralysis | 3 |
Total Records: 1,060 Number of Pages: 53